Cargando…

Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?

Orthopoxvirus (OPV) infections have been present in human life for hundreds of years. It is known that Variola virus (VARV) killed over 300 million people in the past; however, it had an end thanks to the physician Edward Jenner (who developed the first vaccine in history) and also thanks to a massi...

Descripción completa

Detalles Bibliográficos
Autores principales: José da Silva Domingos, Iago, Silva de Oliveira, Jaqueline, Lorene Soares Rocha, Kamila, Bretas de Oliveira, Danilo, Geessien Kroon, Erna, Barbosa Costa, Galileu, de Souza Trindade, Giliane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065508/
https://www.ncbi.nlm.nih.gov/pubmed/33807254
http://dx.doi.org/10.3390/pathogens10040406
_version_ 1783682357837955072
author José da Silva Domingos, Iago
Silva de Oliveira, Jaqueline
Lorene Soares Rocha, Kamila
Bretas de Oliveira, Danilo
Geessien Kroon, Erna
Barbosa Costa, Galileu
de Souza Trindade, Giliane
author_facet José da Silva Domingos, Iago
Silva de Oliveira, Jaqueline
Lorene Soares Rocha, Kamila
Bretas de Oliveira, Danilo
Geessien Kroon, Erna
Barbosa Costa, Galileu
de Souza Trindade, Giliane
author_sort José da Silva Domingos, Iago
collection PubMed
description Orthopoxvirus (OPV) infections have been present in human life for hundreds of years. It is known that Variola virus (VARV) killed over 300 million people in the past; however, it had an end thanks to the physician Edward Jenner (who developed the first vaccine in history) and also thanks to a massive vaccination program in the 20th century all over the world. Although the first vaccine was created using the Cowpox virus (CPXV), it turned out later that the Vaccinia virus was the one used during the vaccination program. VACV is the etiological agent of bovine vaccinia (BV), a zoonotic disease that has emerged in Brazil and South America in the last 20 years. BV has a great impact on local dairy economies and is also a burden to public health. In this review, we described the main events related to VACV and BV emergence in Brazil and South America, the increase of related scientific studies, and the issues that science, human and animal medicine are going to face if we do not be on guard to this virus and its disease.
format Online
Article
Text
id pubmed-8065508
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80655082021-04-25 Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going? José da Silva Domingos, Iago Silva de Oliveira, Jaqueline Lorene Soares Rocha, Kamila Bretas de Oliveira, Danilo Geessien Kroon, Erna Barbosa Costa, Galileu de Souza Trindade, Giliane Pathogens Review Orthopoxvirus (OPV) infections have been present in human life for hundreds of years. It is known that Variola virus (VARV) killed over 300 million people in the past; however, it had an end thanks to the physician Edward Jenner (who developed the first vaccine in history) and also thanks to a massive vaccination program in the 20th century all over the world. Although the first vaccine was created using the Cowpox virus (CPXV), it turned out later that the Vaccinia virus was the one used during the vaccination program. VACV is the etiological agent of bovine vaccinia (BV), a zoonotic disease that has emerged in Brazil and South America in the last 20 years. BV has a great impact on local dairy economies and is also a burden to public health. In this review, we described the main events related to VACV and BV emergence in Brazil and South America, the increase of related scientific studies, and the issues that science, human and animal medicine are going to face if we do not be on guard to this virus and its disease. MDPI 2021-03-31 /pmc/articles/PMC8065508/ /pubmed/33807254 http://dx.doi.org/10.3390/pathogens10040406 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
José da Silva Domingos, Iago
Silva de Oliveira, Jaqueline
Lorene Soares Rocha, Kamila
Bretas de Oliveira, Danilo
Geessien Kroon, Erna
Barbosa Costa, Galileu
de Souza Trindade, Giliane
Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
title Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
title_full Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
title_fullStr Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
title_full_unstemmed Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
title_short Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
title_sort twenty years after bovine vaccinia in brazil: where we are and where are we going?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065508/
https://www.ncbi.nlm.nih.gov/pubmed/33807254
http://dx.doi.org/10.3390/pathogens10040406
work_keys_str_mv AT josedasilvadomingosiago twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing
AT silvadeoliveirajaqueline twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing
AT lorenesoaresrochakamila twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing
AT bretasdeoliveiradanilo twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing
AT geessienkroonerna twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing
AT barbosacostagalileu twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing
AT desouzatrindadegiliane twentyyearsafterbovinevacciniainbrazilwhereweareandwherearewegoing